Robert Spignesi

President and CEO at RAPID MICRO BIOSYSTEMS

Since October 2014

Age

55 years

Education

Holds an M.B.A. from Columbia University and a B.S. in Economics from the United States Military Academy at West Point.

Tenure

Joined RPID as President and Chief Executive Officer in October 2014 and has served on its Board since then.

Also at RAPID MICRO BIOSYSTEMS

John Wilson

Chief Operating Officer

View →

Sean Wirtjes

Chief Financial Officer

View →

About

Robert Spignesi has demonstrated a robust blend of leadership and strategic vision throughout his career. At RPID, he has led initiatives that improved gross margins and exceeded revenue guidance, contributing significantly to the company’s success.

Before joining RPID, he built an impressive track record in high-impact roles, including serving as Vice President & General Manager, Americas at Thermo Fisher Scientific and as Vice President of Global Strategy, Business Development, and Marketing at Fisher Scientific. His early career as an Aviation Officer with the U.S. Army further instilled a strong sense of discipline and strategic thinking.

His tenure at RPID is marked by forward-thinking achievements such as forging key strategic agreements, including the global Distribution and Collaboration Agreement with MilliporeSigma, reflecting his commitment to sustainable growth and operational excellence. These accomplishments underscore a career built on deep industry expertise and innovative leadership.

$RPID Performance Under Robert Spignesi

Past Roles

Organization	Role	Date Range	Details
Thermo Fisher Scientific	Vice President & General Manager, Americas of the Microbiology Division	N/A	N/A
Fisher Scientific	Vice President of Global Strategy, Business Development, and Marketing	N/A	N/A
U.S. Army	Aviation Officer	N/A	N/A

Fixed Compensation

Data from FY 2023

Component Name	Amount	Payment Schedule	Additional Details
Base Salary	$616,512	Annual 2023	4% increase from 2022
Other Compensation	$34,990	Annual 2023	Includes $12,075 (401(k) matching) , $520 (life insurance premiums) , $22,395 (medical insurance premiums)

Performance Compensation

Data from FY 2023

Annual Performance Bonus (Cash Incentive)

Metric	Weight (%)	Achievement (%)	Earned Payout (%)
Commercial Execution and Revenue Growth	50%	76%	29%
New Product Development	20%	100%	20%
Customer Experience	10%	127%	13%
Gross Margin Improvement	10%	0%	0%
Employee Engagement, Recruitment, and Development	10%	200%	20%
Total	100%	N/A	81%

Target Bonus: Set at 80% of base salary of $616,512 , resulting in an approximate cash payout of $401,218.
Evaluation Period: 2023 with bonus payout determined in January 2024.
Vesting: This cash incentive is paid outright with no vesting schedule.

Performance-Based Restricted Stock Units (PRSUs)

Outstanding Units: 380,975 PRSUs as of December 31, 2023.
Market Value: $281,922 at a trading price of $0.74 per share.
Grant Date Stock Price: $1.22 (weighted average fair value).
Vesting Schedule: Vests upon achievement of specified corporate performance goals prior to March 10, 2027 and fully vests upon a Change of Control.
Performance Metrics: No detailed performance thresholds or targets for the RSUs are provided.